title: An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.
authors.affiliation: Mission Internal Medical Group, Mission Viejo, CA, USA.
authors.forename: Michael I
authors.initials: MI
authors.lastname: Miyamoto
authors.forename: Kyle A
authors.initials: KA
authors.lastname: Clarke
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Thomas
authors.forename: Luiz
authors.initials: L
authors.lastname: Belardinelli
mesh_terms: D000241:Adenosine / Q000494:pharmacology; D058908:Adenosine A2 Receptor Agonists / Q000494:pharmacology; D058917:Adenosine A2 Receptor Antagonists / Q000494:pharmacology*; D000368:Aged; D054316:Biomarkers, Pharmacological; D055426:Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; D005080:Exercise Test; D006801:Humans; D008297:Male; D055414:Myocardial Perfusion Imaging; D011687:Purines / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D043705:Receptor, Adenosine A2A / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D058908:Adenosine A2 Receptor Agonists; D058917:Adenosine A2 Receptor Antagonists; D054316:Biomarkers, Pharmacological; D011687:Purines; D011720:Pyrazoles; D043705:Receptor, Adenosine A2A; D014665:Vasodilator Agents; C430916:regadenoson; D000241:Adenosine